Home › Peripheral Arterial Disease › Nebraska › Omaha
Peripheral Arterial Disease clinical trials in Omaha, NE
7 studies for Peripheral Arterial Disease are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Detecting Peripheral Artery Disease With the Pulse
RecruitingHealthy volunteers welcome
- University of Nebraska at Omaha Health Science Collaborative, Omaha
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
RecruitingEarly phase 1Healthy volunteers welcome
- University of Nebraska - Omaha, Omaha
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
Recruiting
- VA Medical Center, Omaha
Oxygen-guided Supervised Exercise Therapy
Recruiting
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
RecruitingPhase 4
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
Recruiting
- University of Nebraska Medical Center, Omaha
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RecruitingPhase 4
- VA Medical Center, Omaha
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Chicago, IL9 studies
- Dallas, TX9 studies
- Cleveland, OH9 studies
- Boston, MA9 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Nashville, TN6 studies
- Aurora, CO6 studies
- Miami, FL6 studies
- Minneapolis, MN6 studies
- Norfolk, VA5 studies
- Detroit, MI5 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Colorectal Cancer18 studies
- Cancer (all types)18 studies
- Multiple Myeloma16 studies
- Non-Hodgkin Lymphoma14 studies
- Ovarian Cancer14 studies
- Pancreatic Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
- Metastatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.